Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
dalfampridine (ampyra) (1 trial)
vx15/2503 (1 trial)
Multiple Sclerosis (Phase 3)
Sclerosis (Phase 3)
Trials (2 total)
Trial APIs (2 total)